Silvestris F - Search Results

1

Ovarian cancer: Novel molecular aspects for clinical assessment.

Palmirotta R, Silvestris E, D'Oronzo S, Cardascia A, Silvestris F. Palmirotta R, et al. Among authors: silvestris f, silvestris e. Crit Rev Oncol Hematol. 2017 Sep;117:12-29. doi: 10.1016/j.critrevonc.2017.06.007. Epub 2017 Jun 17. Crit Rev Oncol Hematol. 2017. PMID: 28807232 Review.

2

Uterine carcinosarcoma: An overview.

Pezzicoli G, Moscaritolo F, Silvestris E, Silvestris F, Cormio G, Porta C, D'Oronzo S. Pezzicoli G, et al. Among authors: silvestris f. Crit Rev Oncol Hematol. 2021 Jul;163:103369. doi: 10.1016/j.critrevonc.2021.103369. Epub 2021 May 27. Crit Rev Oncol Hematol. 2021. PMID: 34051304 Review.

3

Pharmacogenetics and pharmacogenomics: role of mutational analysis in anti-cancer targeted therapy.

Savonarola A, Palmirotta R, Guadagni F, Silvestris F. Savonarola A, et al. Among authors: silvestris f. Pharmacogenomics J. 2012 Aug;12(4):277-86. doi: 10.1038/tpj.2012.28. Epub 2012 Jul 3. Pharmacogenomics J. 2012. PMID: 22760589 Review.

4

[Cell-based strategies: novel perspectives for cancer therapy].

Simone V, Ciavarella S, D'Oronzo S, Silvestris F. Simone V, et al. Among authors: silvestris f. Recenti Prog Med. 2012 Feb;103(2):49-55. doi: 10.1701/1045.11385. Recenti Prog Med. 2012. PMID: 22430747 Review. Italian.

5

Therapeutic approaches to myeloma bone disease: an evolving story.

Longo V, Brunetti O, D'Oronzo S, Dammacco F, Silvestris F. Longo V, et al. Among authors: silvestris f. Cancer Treat Rev. 2012 Oct;38(6):787-97. doi: 10.1016/j.ctrv.2012.03.004. Epub 2012 Apr 9. Cancer Treat Rev. 2012. PMID: 22494965 Review.

6

Everolimus restrains the IL-17A-dependent osteoclast-like transdifferentiation of dendritic cells in multiple myeloma.

Tucci M, Stucci S, Passarelli A, D'Oronzo S, Silvestris F. Tucci M, et al. Among authors: silvestris f. Exp Hematol. 2017 Mar;47:48-53. doi: 10.1016/j.exphem.2016.10.004. Epub 2016 Oct 17. Exp Hematol. 2017. PMID: 27765615 Free article.

7

ALK gene alterations in cancer: biological aspects and therapeutic implications.

Palmirotta R, Quaresmini D, Lovero D, Silvestris F. Palmirotta R, et al. Among authors: silvestris f. Pharmacogenomics. 2017 Feb;18(3):277-292. doi: 10.2217/pgs-2016-0166. Epub 2017 Jan 23. Pharmacogenomics. 2017. PMID: 28112990

8

Next-generation Sequencing (NGS) Analysis on Single Circulating Tumor Cells (CTCs) with No Need of Whole-genome Amplification (WGA).

Palmirotta R, Lovero D, Silvestris E, Felici C, Quaresmini D, Cafforio P, Silvestris F. Palmirotta R, et al. Among authors: silvestris f, silvestris e. Cancer Genomics Proteomics. 2017 May-Jun;14(3):173-179. doi: 10.21873/cgp.20029. Cancer Genomics Proteomics. 2017. PMID: 28446532 Free PMC article.

9

Immune-related adverse events during anticancer immunotherapy: Pathogenesis and management.

Stucci S, Palmirotta R, Passarelli A, Silvestris E, Argentiero A, Lanotte L, Acquafredda S, Todisco A, Silvestris F. Stucci S, et al. Among authors: silvestris f, silvestris e. Oncol Lett. 2017 Nov;14(5):5671-5680. doi: 10.3892/ol.2017.6919. Epub 2017 Sep 8. Oncol Lett. 2017. PMID: 29113194 Free PMC article.

10

In vitro differentiation of human oocyte-like cells from oogonial stem cells: single-cell isolation and molecular characterization.

Silvestris E, Cafforio P, D'Oronzo S, Felici C, Silvestris F, Loverro G. Silvestris E, et al. Among authors: silvestris f. Hum Reprod. 2018 Mar 1;33(3):464-473. doi: 10.1093/humrep/dex377. Hum Reprod. 2018. PMID: 29304224

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

227 results

Search Page